Northwestern Mutual Wealth Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-40
Closed -$436 – 4350
2026
Q1
$436 Buy
+40
New +$500 ﹤0.01% 3866
2025
Q3
– Sell
-1
Closed -$18 – 3975
2025
Q2
$18 Buy
+1
New +$17 ﹤0.01% 3616
2025
Q1
– Sell
-319
Closed -$9.51K – 3863
2024
Q4
$9.51K Buy
+319
New +$6.75K ﹤0.01% 2754
2024
Q2
– Sell
-128
Closed -$2K – 3719
2024
Q1
$2K Buy
+128
New +$1.88K ﹤0.01% 3048
2023
Q3
– Sell
-3
Closed -$125 – 3465
2023
Q2
$125 Sell
3
-102
-97% -$6.33K ﹤0.01% 3257
2023
Q1
$6.32K Sell
105
-95
-48% -$7.59K ﹤0.01% 2672
2022
Q4
$14.7K Hold
200
– – ﹤0.01% 2358
2022
Q3
$15K Buy
200
+139
+228% +$10.8K ﹤0.01% 2326
2022
Q2
$4K Buy
61
+60
+6,000% +$4.52K ﹤0.01% 2781
2022
Q1
$0 Sell
1
-19
-95% -$1.4K ﹤0.01% 3310
2021
Q4
$2K Buy
20
+6
+43% +$602 ﹤0.01% 2960
2021
Q3
$2K Sell
14
-131
-90% -$19.8K ﹤0.01% 2865
2021
Q2
$32K Buy
+145
New +$28.2K ﹤0.01% 2009
2020
Q2
– Sell
-15
Closed -$1K – 2585
2020
Q1
$1K Buy
15
+12
+400% +$948 ﹤0.01% 2431
2019
Q4
$0 Buy
+3
New +$242 ﹤0.01% 2552
2016
Q2
– Sell
-250
Closed -$4K – 2195
2016
Q1
$4K Buy
+250
New +$3.59K ﹤0.01% 1722

Other funds holding NVCR

Northwestern Mutual Wealth Management's NVCR Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of NovoCure (NVCR) in Q2 2026, closing a stake of 40 shares — an estimated $436 sold.

Northwestern Mutual Wealth Management first reported a position in NVCR in Q1 2016 and held it in 16 quarters. The position peaked at $32K in Q2 2021. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining NovoCure position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 40 NovoCure shares in Q2 2026, an estimated $436.
  • Northwestern Mutual Wealth Management first reported a position in NovoCure in Q1 2016 and held it in 16 quarters.
  • Northwestern Mutual Wealth Management's NovoCure position peaked at $32K in Q2 2021.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.